Spyre Therapeutics, Inc. · NASDAQ:SYRE

Spyre Therapeutics, Inc. insider trades

Spyre Therapeutics, Inc.'s insiders made 0 buys and 83 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

DateInsiderTradeSharesPriceFiling
Oct 1, 2026Burrows Scott LSale600US$89Form 4
Oct 1, 2026Burrows Scott LSale1,500US$90Form 4
Oct 1, 2026Burrows Scott LSale2,100US$92Form 4
Oct 1, 2026Burrows Scott LSale3,071US$93Form 4
Oct 1, 2026Burrows Scott LSale229US$94Form 4
Oct 1, 2026King-Jones HeidySale400US$89Form 4
Oct 1, 2026King-Jones HeidySale16,605US$90Form 4
Oct 1, 2026King-Jones HeidySale7,228US$91Form 4
Oct 1, 2026King-Jones HeidySale2,100US$93Form 4
Oct 1, 2026King-Jones HeidySale2,600US$93Form 4

Spyre Therapeutics, Inc. shareholders